Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Naltrexone HCl 1%/Azelastine HCl 0.15% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design allows for easy and precise application on the skin, targeting the treatment or absorption of active ingredients in a gel-like consistency. It is a compounded medication used to treat conditions such as Atopic Dermatitis, Allergic Rhinitis, Pruritus, Psoriasis, and Urticaria.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specialized topical gel formulation of Naltrexone HCl 1%/Azelastine HCl 0.15%. This unique combination of medications is designed to address a range of skin conditions, such as eczema, psoriasis, and atopic dermatitis. The Naltrexone HCl 1% component works to alleviate inflammation and itching, while the Azelastine HCl 0.15% component aids in reducing redness and swelling.
This topical gel formulation is a semisolid preparation dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients. It is designed to be applied directly to the affected area, following the instructions provided by your healthcare provider. Please note that this medication should not be used on broken or irritated skin.
If you have any queries about this compounded formulation or how it can assist in treating your skin condition, please do not hesitate to contact us at Bayview Pharmacy. We are committed to helping you find the most suitable treatment option for your specific needs. Please remember, it is essential to consult with your healthcare provider before starting any new medication regimen.
Naltrexone HCl 1%/Azelastine HCl 0.15% Topical Gel is a compounded formulation designed for the treatment of moderate to severe atopic dermatitis, psoriasis, and other inflammatory skin conditions. This semisolid formulation is dispensed through a pump mechanism, allowing for easy and precise application on the skin. The active ingredients in this gel-like consistency are absorbed into the skin, providing targeted treatment to the affected areas.
The combination of naltrexone and azelastine in this formulation works by blocking the release of certain inflammatory substances in the body. This action helps to reduce inflammation and itching associated with various skin conditions. It is recommended that patients apply the gel to the affected area twice daily, or as directed by their healthcare provider.
Patients should be aware that this medication may cause skin irritation, burning, or stinging. If these side effects occur, it is advised to contact their healthcare provider immediately. Additionally, this medication may cause drowsiness or dizziness. Patients should exercise caution when driving or operating machinery while using this medication.
It is important to note that this medication may interact with other medications, including certain antibiotics, antifungals, and anticonvulsants. Therefore, patients should inform their healthcare provider of all medications they are currently taking before starting the use of Naltrexone HCl 1%/Azelastine HCl 0.15% Topical Gel.
If you have any questions or concerns about using Naltrexone HCl 1%/Azelastine HCl 0.15% Topical Gel, please do not hesitate to reach out to your healthcare provider for further guidance and information.
Naltrexone HCl 1%/Azelastine HCl 0.15% Topical Gel is a compounded formulation designed to address a range of skin conditions such as eczema, psoriasis, and atopic dermatitis. This unique combination of active ingredients, naltrexone hydrochloride and azelastine hydrochloride, synergistically work to alleviate inflammation and itching associated with these skin conditions.
Naltrexone hydrochloride, an opioid antagonist, plays a crucial role in reducing inflammation and itching. On the other hand, azelastine hydrochloride, an antihistamine, contributes to the reduction of itching and redness. Together, these ingredients provide a comprehensive approach to managing the symptoms of various skin conditions.
Upon application to the affected skin area, the gel formulation acts by inhibiting the release of histamine, a chemical that triggers inflammation and itching. Additionally, it curbs the production of other chemicals that can instigate inflammation and itching. The combined effect of naltrexone hydrochloride and azelastine hydrochloride effectively mitigates the symptoms associated with these skin conditions.
The Naltrexone HCl 1%/Azelastine HCl 0.15% Topical Gel is dispensed through a pump mechanism, which allows for easy and precise application. This semisolid formulation should be applied to the affected area twice daily, or as directed by your healthcare provider. It is crucial to adhere to the instructions on the label and use the medication as directed for optimal results.
If you have any queries regarding the usage of this medication, it is recommended to consult with your healthcare provider. Remember, proper application and adherence to the prescribed regimen is key to achieving the desired therapeutic outcomes.
This is a compounded formulation that combines Naltrexone HCl at 1% and Azelastine HCl at 0.15% in a gel form. It is designed to be applied topically on the skin for targeted treatment.
This formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The formulation is a semisolid, similar to a gel. This consistency allows for easy application and absorption of the active ingredients into the skin.
You should apply this gel directly to the skin in the area that needs treatment. The pump mechanism allows for precise application.
The active ingredients in this formulation are Naltrexone HCl at 1% and Azelastine HCl at 0.15%.
Naltrexone HCl is used in this formulation for its therapeutic effects. It is often used in the treatment of certain addictive disorders, but its use in this topical formulation may vary depending on the specific treatment goals.
Azelastine HCl is an antihistamine that is used to reduce inflammation and allergic reactions. In this topical formulation, it may be used to treat skin conditions related to allergies or inflammation.
This formulation should only be used under the direction of a healthcare provider. It is important to discuss your medical history and current medications with your provider before starting any new treatment.
As with any medication, there may be potential side effects. It is important to discuss these with your healthcare provider before starting treatment. If you experience any adverse reactions while using this formulation, contact your healthcare provider immediately.
This formulation should be stored at room temperature, away from heat and direct light. Keep the container tightly closed when not in use. Always keep this and all medications out of the reach of children.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
